Israeli Capital Market Authority Seeks New Limits on Institutional Investors’ Corporate Influence
Two days ago, it was revealed that Amit Gal, head of Israel's Capital Market Authority, requested clarifications from investment house Meor regarding its intention to appoint four directors to Orion, a small publicly traded company holding three real estate assets in Poland valued at about 94 million shekels. Gal expressed concern that Meor’s involvement might exceed what is expected of institutional investors and could amount to management interference or influence inconsistent with regulatory limits.
This letter sparked significant debate across Israel’s capital market and social sectors, including a detailed response from Lobby 99, which warned that Gal’s stance might chill institutional investors’ willingness to oversee public companies, potentially harming pension savers’ interests. Institutional investors, such as insurance companies and investment houses, manage approximately 3.4 trillion shekels, with around 500 billion shekels invested in local equities. Their active involvement is seen as crucial for improving company profitability but also raises concerns about market concentration and conflicts of interest.
Israeli law restricts institutional investors from holding more than 20% in any public company to prevent excessive control, yet regulators expect them to actively monitor corporate governance, a practice known as "institutional activism." Gal’s letter surprised many because it signals a policy shift away from encouraging such activism, emphasizing that institutional investors should remain financial investors rather than controlling shareholders. Gal had previously stated that maintaining this balance is vital for healthy market growth.
Critics argue that the concerns raised about Meor’s involvement in a relatively small foreign company seem disproportionate and that if there are broader issues with institutional activism, the regulator should address them through formal studies and regulations rather than isolated interventions. The Capital Market Authority recently requested data on institutional investors’ interventions over the past three years, a routine measure unrelated to this specific case but potentially informative for future actions.
The debate over the appropriate level of institutional investor involvement in public companies is expected to continue, reflecting a complex balance between protecting pension savers’ interests and preventing market dominance by a few large players. While the Authority’s approach may have started awkwardly, finding a middle ground that ensures effective oversight without excessive control remains essential for Israel’s financial system.
